From Architecture to Outcomes: Mapping the Landscape of Digital Twins for Personalized Diabetes Care—A Scoping Review

<b>Background/Objectives</b>: Digital twins are emerging as a transformative technology in diabetes management, promising a shift from standardized protocols to highly personalized care. This scoping review aims to systematically map the current landscape of digital twin applications in diabetes, synthesizing evidence on their implementation architectures, analytical models, performance metrics, and clinical integration strategies to identify key trends and critical gaps. <b>Methods</b>: A systematic search was conducted across five electronic databases in accordance with PRISMA-ScR guidelines to identify empirical studies on digital twins for diabetes. Data from the selected articles were extracted to analyze bibliographic characteristics, population data, technological components, performance outcomes, and integration levels. A narrative synthesis was performed to map the evidence. <b>Results</b>: Seventeen studies were included, revealing a rapid increase in publications since 2022, with a notable concentration of research in India. The technological architecture shows a convergence toward machine learning models (e.g., LSTM) powered by data from IoT devices and wearables. Certain interventional studies have reported significant clinical impacts, including HbA1c reductions of up to 1.9% and T2DM remission rates as high as 76.5% in one trial. However, major implementation barriers were identified, including fragmented interoperability standards and low rates of full integration into clinical workflows (35.3%). <b>Conclusions</b>: Digital twins are emerging as powerful tools that show the potential to drive significant clinical outcomes in diabetes care. However, to translate this promise into widespread practice, future efforts must focus on overcoming the critical challenges of standardized interoperability and deep clinical integration. Rigorous, independently validated, long-term trials in diverse populations are essential to confirm these promising findings.

Authors

Institutions

Publication Details

Journal
Journal of Personalized Medicine
Published
2025-10-23
DOI
https://doi.org/10.3390/jpm15110504
Citations
1
Primary Topic
Health, Environment, Cognitive Aging
Type
article
Field-Weighted Citation Impact
1.20
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From Architecture to Outcomes: Mapping the Landscape of Digital Twins for Personalized Diabetes Care—A Scoping Review

Jhony Alejandro Díaz-Vallejo, Yamil Liscano, Danilo Andrés Cáceres-Gutiérrez
1 citations
Journal of Personalized Medicine
Health, Environment, Cognitive Aging
1.20
article

From Architecture to Outcomes: Mapping the Landscape of Digital Twins for Personalized Diabetes Care—A Scoping Review

Jhony Alejandro Díaz-Vallejo, Yamil Liscano, Danilo Andrés Cáceres-Gutiérrez
article en
1 citations

Abstract

<b>Background/Objectives</b>: Digital twins are emerging as a transformative technology in diabetes management, promising a shift from standardized protocols to highly personalized care. This scoping review aims to systematically map the current landscape of digital twin applications in diabetes, synthesizing evidence on their implementation architectures, analytical models, performance metrics, and clinical integration strategies to identify key trends and critical gaps. <b>Methods</b>: A systematic search was conducted across five electronic databases in accordance with PRISMA-ScR guidelines to identify empirical studies on digital twins for diabetes. Data from the selected articles were extracted to analyze bibliographic characteristics, population data, technological components, performance outcomes, and integration levels. A narrative synthesis was performed to map the evidence. <b>Results</b>: Seventeen studies were included, revealing a rapid increase in publications since 2022, with a notable concentration of research in India. The technological architecture shows a convergence toward machine learning models (e.g., LSTM) powered by data from IoT devices and wearables. Certain interventional studies have reported significant clinical impacts, including HbA1c reductions of up to 1.9% and T2DM remission rates as high as 76.5% in one trial. However, major implementation barriers were identified, including fragmented interoperability standards and low rates of full integration into clinical workflows (35.3%). <b>Conclusions</b>: Digital twins are emerging as powerful tools that show the potential to drive significant clinical outcomes in diabetes care. However, to translate this promise into widespread practice, future efforts must focus on overcoming the critical challenges of standardized interoperability and deep clinical integration. Rigorous, independently validated, long-term trials in diverse populations are essential to confirm these promising findings.

Journal of Personalized MedicineVol. 15(11)
University of Caldas (CO), Universidad Santiago de Cali (CO), Universidad Autónoma de Occidente (CO)
Openalex Percentile: Top 17%
Health, Environment, Cognitive Aging
1.20
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.